QUESTRAN

This brand name is authorized in Australia, Brazil, Germany, Estonia, Finland, France, Ireland, Japan, Netherlands, New Zealand, United Kingdom, United States, South Africa

Active ingredients

The drug QUESTRAN contains one active pharmaceutical ingredient (API):

1 Colestyramine
UNII 4B33BGI082 - CHOLESTYRAMINE

Colestyramine resin absorbs and combines with the bile acids in the intestine to form an insoluble complex which is excreted in the faeces. This results in an increased faecal loss of bile acids which leads to an increased oxidation of cholesterol to bile acids and a decrease in serum cholesterol levels and low density lipoprotein serum levels.

Read about Colestyramine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
QUESTRAN Powder for oral suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C10AC01 Colestyramine C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AC Bile acid sequestrants
Discover more medicines within C10AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 2967E, 9249T
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 505105101136318, 562620060000717
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 00869146, 04370366
Country: EE Ravimiamet Identifier(s): 1123513, 1510535, 1605271, 1753961
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 160531
Country: FR Base de données publique des médicaments Identifier(s): 65691327
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 32654
Country: IE Health Products Regulatory Authority Identifier(s): 44329, 55591
Country: JP 医薬品医療機器総合機構 Identifier(s): 2189009R1032
Country: NL Z-Index G-Standaard, PRK Identifier(s): 62820, 62839
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 1208
Country: US FDA, National Drug Code Identifier(s): 49884-936, 49884-937
Country: ZA Health Products Regulatory Authority Identifier(s): D/7.5/39

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.